|
Association of Covid-19 Infection with Liver Tests and Pregnancy Outcomes: A Prospective Cohort Study
|
M Valizadeh1   , Z Mahmoodi2 , M Bakhtiari3 , M Moosavian4 , M Yazdkhasti5 |
1- Department of Midwifery, Alborz University of Medical Sciences, Alborz, Iran
2- Center for Social Determinants of Health, Directorate of the Center for Determinants of Health (SDH), Alborz University of Medical Sciences, Alborz, Iran
3- Department of Epidemiology and Biostatistics, Alborz University of Medical Sciences, Alborz, Iran
4- Department of Internal Medicine, Alborz University of Medical Sciences, Alborz, Iran
5- Department of Midwifery, Alborz University of Medical Sciences, Alborz, Iran , Mansoyazd@yahoo.com |
|
|
Abstract: (861 Views) |
Background & aim: With the spread of the newly emerging virus, Covid-19, there were many concerns about the effects and complications of pregnant women contracting this virus. Since pregnant women are in a vulnerable group due to the physiological changes associated with pregnancy, the purpose of the present study was to determine and relate the infection of covid-19 with liver tests and pregnancy outcomes.
Methods: The present prospective cohort study was conducted from October 2019 to September 2021 at Shahid Akbarabadi and Firouzgar educational centers of Tehran, Iran. In this study, 191 female patients were included in the study and divided into two groups: 1- pregnant women infected with covid-19 (case group), 2- pregnant women not infected with covid-19 (control group). Eligible people were initially included in the study by available method and then by simple random allocation. Data collection was done by demographic and fertility questionnaires, pain (VAS) and relevant checklists. Collected data were analyzed using t-test, Mann-Whitney, chi-square, Fisher's exact test, Spearman, Pearson and logistic regression.
Results: The level of liver tests (International Normalized Ratio(INR), aspartate aminotransferase (AST), alanine aminotransferase (ALT, ALP, alkaline phosphatase) increased between the two groups. The increase between the two groups indicated a statistically significant difference (p<0.001), but the mean platelet, indirect bilirubin and relative thromboplastin time in the case group were significantly lower than the control group respectively (p<0.002, p<0.001, 041. Moreover, there was a significant difference in premature delivery and the intensity of contractions in the case and control groups (p<0.001). Phosphatase increased ALP by 15% and indirect bilirubin risk by 58%, which was reported to be statistically significant, but it had no effect on platelets and INR.
Conclusion: Based on the results of the present study, the infection of covid-19 caused liver test disorders. Disruption of liver tests due to covid-19 infection can overlap the changes made during preeclampsia syndrome or HELLP syndrome (hemolysis, increase of liver enzymes, decrease of platelets). Furthermore, the covid-19 infection increased the intensity of contractions and premature delivery.
|
|
| Keywords: COVID-19 virus, Pregnancy, Liver tests, Pregnancy outcome |
|
|
Full-Text [PDF 1342 kb]
(113 Downloads)
|
Type of Study: Research |
Subject:
Clinical
Received: 2023/09/29 | Accepted: 2024/09/25 | Published: 2024/10/6
|
|
|
|
|
|
|
| References |
1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine 2020; 382(8): 727-33.## [ DOI:10.1056/NEJMoa2001017] [ PMID] [ ] 2. Mullins E, Evans D, Viner R, O'Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound in Obstetrics & Gynecology 2020; 55(5): 586-92.## [ DOI:10.1002/uog.22014] [ PMID] 3. Castro P, Matos AP, Werner H, Lopes FP, Tonni G, Araujo Júnior E. Covid-19 and pregnancy: an overview. Revista Brasileira de Ginecologia e Obstetrícia 2020; 42: 420-6.## [ DOI:10.1055/s-0040-1713408] [ PMID] [ ] 4. Ntounis T, Prokopakis I, Koutras A, Fasoulakis Z, Pittokopitou S, Valsamaki A, et al. Pregnancy and COVID-19. Journal of Clinical Medicine 2022; 11(22): 6645.## [ DOI:10.3390/jcm11226645] [ PMID] [ ] 5. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Bmj 2020; 368: 1-11.## [ DOI:10.1136/bmj.m1091] [ PMID] [ ] 6. Chelsea Elwood M, Isabelle Boucoiran M, Julie VanSchalkwyk M, Deborah Money M, Mark Yudin M, Vanessa Poliquin M. SOGC committee opinion-COVID-19 in pregnancy. Journal of Obstetrics and Gynaecology Canada 2020; S1701-2163(20): 30274-7.## [ DOI:10.1016/j.jogc.2020.03.012] [ ] 7. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. American Journal of Obstetrics and Gynecology 2004; 191(1): 292-7.## [ DOI:10.1016/j.ajog.2003.11.019] [ PMID] [ ] 8. Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. The Pediatric Infectious Disease Journal 2020; 39(6): 469.## [ DOI:10.1097/INF.0000000000002700] [ PMID] [ ] 9. Shekarriz-Foumani R, Yassaee F, Tarokh S, Taheri M. Pregnancy outcomes in women with liver disease: Is pregnancy safe? A cross-sectional study. International Journal of Reproductive BioMedicine 2020; 18(10): 899.## [ DOI:10.18502/ijrm.v13i10.7774] [ PMID] [ ] 10. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Williams obstetrics. 26th ed: McGraw-Hill Medical New York; 2022.## 11. Mikolasevic I, Filipec-Kanizaj T, Jakopcic I, Majurec I, Brncic-Fischer A, Sobocan N, et al. Liver disease during pregnancy: a challenging clinical issue. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2018; 24: 4080.## [ DOI:10.12659/MSM.907723] [ PMID] [ ] 12. Jamjute P, Ahmad A, Ghosh T, Banfield P. Liver function test and pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine 2009; 22(3): 274-83.## [ DOI:10.1080/14767050802211929] [ PMID] 13. De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology 2016; 14(8): 523-34.## [ DOI:10.1038/nrmicro.2016.81] [ PMID] [ ] 14. Liang W, Liang H, Ou L, Chen B, Chen A, Li C, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Internal Medicine 2020; 180(8): 1081-9.## [ DOI:10.1001/jamainternmed.2020.2033] [ PMID] [ ] 15. Bakhshi Mofrad Kashani A, Asalani Mehr M, Abedi Elkhichi P. Challenges Of laboratory sampling and diagnosis of sars-cov-2 virus of disease(Covid-19). Studies in Medical Sciences 2021; 32(3): 156-74.## 16. Amiri A, Yusefi R, Habibi-Rezaei M, Haghparas Z, Danesh N, Moghadamnia SH, et al. SARS-CoV-2 virus essential proteins and its mutational changes. Iranian Journal of Culture and Health Promotion 2023; 7(1): 119-121.## 17. Ghelmani SY, Salehabadi HS, Moazen H, Nazmiah H, Tafti TF, Kabirzadeh A, et al. Evaluation of risk factors related to life status of patients with covid-19 hospitalized in Yazd. The Journal of Tolooebehdasht 2022; 21(2): 85-98.## [ DOI:10.18502/tbj.v21i2.10343] 18. Rostami A, Birang N. Pregnancy outcomes among pregnant women infected with COVID-19 with and without underlying disease: A case-control study. Journal of Family Medicine and Primary Care 2022; 11(9): 5305.## [ DOI:10.4103/jfmpc.jfmpc_1291_21] [ PMID] [ ] 19. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology 2020; 20(6): 363-74.## [ DOI:10.1038/s41577-020-0311-8] [ PMID] [ ] 20. Wastnedge EA, Reynolds RM, Van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiological reviews 2020; 101(1): 303-18.## [ DOI:10.1152/physrev.00024.2020] [ PMID] [ ] 21. Zhang L, Jiang Y, Wei M, Cheng B, Zhou X, Li J, et al. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province. Zhonghua Fu Chan Ke Za Zhi 2020; 55(3): 166-171.## 22. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. The Lancet Infectious Diseases 2020; 20(5): 559-64.## [ DOI:10.1016/S1473-3099(20)30176-6] [ PMID] 23. Tabatabai RS, Asadi L, Mohammadi M, Rahmani M, Rezaeian E, Ghasemi F, et al. Prenatal and clinical characteristics of pregnant women infected with COVID-19 in Yazd, Iran: A multicenter cross-sectional study. International Journal of Reproductive BioMedicine 2022; 20(7): 529.## [ DOI:10.18502/ijrm.v20i7.11555] [ PMID] [ ] 24. Omrani-Nava V, Maleki I, Ahmadi A, Moosazadeh M, Hedayatizadeh-Omran A, Roozbeh F, et al. Evaluation of hepatic enzymes changes and association with prognosis in COVID-19 patients. Hepatitis Monthly 2020; 20(4): 10317.## [ DOI:10.5812/hepatmon.103179] 25. Wu Y, Li H, Guo X, Yoshida EM, Mendez-Sanchez N, Levi Sandri GB, et al. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. Hepatology International 2020; 14: 621-37.## [ DOI:10.1007/s12072-020-10074-6] [ PMID] [ ] 26. Sun G, Zhang Y, Liao Q, Cheng Y. Blood test results of pregnant COVID-19 patients: an updated case-control study. Frontiers in Cellular and Infection Microbiology 2020; 10: 560899.## [ DOI:10.3389/fcimb.2020.560899] [ PMID] [ ] 27. Nazarpour S, Simbar M. A systematic review of pregnancy outcomes in mothers with covid-19 infection. Nursing And Midwifery Journal 2023; 21(1): 78-88.## [ DOI:10.61186/unmf.21.1.78] 28. Boureau F, Luu M, Doubrère JF. Comparative study of the validity of four French McGill Pain Questionnaire(MPQ) versions. Pain 1992; 50(1): 59-65.## [ DOI:10.1016/0304-3959(92)90112-O] [ PMID] 29. Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire(SF-MPQ-2). Pain 2009; 144(1-2): 35-42.## [ DOI:10.1016/j.pain.2009.02.007] [ PMID] 30. Harding C, McVey F. Interview method affects incidence of postoperative sore throat. Anaesthesia 1987; 42(10): 1104-7.## [ DOI:10.1111/j.1365-2044.1987.tb05179.x] [ PMID] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Valizadeh M, Mahmoodi Z, Bakhtiari M, Moosavian M, Yazdkhasti M. Association of Covid-19 Infection with Liver Tests and Pregnancy Outcomes: A Prospective Cohort Study. armaghanj 2024; 29 (5) :693-706 URL: http://armaghanj.yums.ac.ir/article-1-3526-en.html
|
